ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,058.55
0.32%
US Tech 100
20,867.01
0.16%
Dow Jones
44,855.56
0.32%
Brent Oil
75.90
-0.03%
Bitcoin
105,420.57
1.62%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Praxis Precision Medicines Inc (PRAX) Quote

Praxis Precision Medicines Inc

Praxis Precision Medicines Inc (PRAX)

NASDAQ
76.11
2.09
( 2.82% )
Updated: 11:49:28
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
76.11
Bid
76.01
Ask
76.56
Volume
113,146
74.01 Day's Range 76.55
33.01 52 Week Range 86.93
Market Cap
1.419B
Previous Close
74.02
Open
74.61
Last Trade
55
@
76.2081
Last Trade Time
11:49:44
Financial Volume
$ 8,563,610
VWAP
75.6864
Average Volume (3m)
352,549
Shares Outstanding
18,637,777
Dividend Yield
-
PE Ratio
-11.51
Earnings Per Share (EPS)
-6.61
Revenue
2.45M
Net Profit
-123.28M

About Praxis Precision Medicines Inc

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, fo... Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.praxismedicines.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Praxis Precision Medicines Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRAX. The last closing price for Praxis Precision Medicines was $74.02. Over the last year, Praxis Precision Medicines shares have traded in a share price range of $ 33.01 to $ 86.93.

Praxis Precision Medicines currently has 18,637,777 shares outstanding. The market capitalization of Praxis Precision Medicines is $1.38 billion. Praxis Precision Medicines has a price to earnings ratio (PE ratio) of -11.51.

Ask ADVFN Intelligence (AI)

PRAX Latest News

More News

Form 8-K - Current report

19 hours ago
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 14 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 14 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 14 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 14 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 08 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 08 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 08 2025
Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

December 23 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 19 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.54-1.9832582099277.6578.6170.826042274.93375826CS
4-0.07-0.091887634549876.1882.615660.0734430373.67329398CS
124.145.7523968320171.9786.9360.0735254974.56600398CS
2618.5132.135416666757.686.9348.2230272668.09321305CS
5235.185.588880760841.0186.9333.0129268258.2600631CS
156-126.69-62.4704142012202.8226.211.8578020037.57647994CS
260-332.04-81.3524439544408.15914.257511.8562767685.12286248CS

PRAX - Frequently Asked Questions (FAQ)

What is the current Praxis Precision Medicines share price?
The current share price of Praxis Precision Medicines is $ 76.11
How many Praxis Precision Medicines shares are in issue?
Praxis Precision Medicines has 18,637,777 shares in issue
What is the market cap of Praxis Precision Medicines?
The market capitalisation of Praxis Precision Medicines is USD 1.38B
What is the 1 year trading range for Praxis Precision Medicines share price?
Praxis Precision Medicines has traded in the range of $ 33.01 to $ 86.93 during the past year
What is the PE ratio of Praxis Precision Medicines?
The price to earnings ratio of Praxis Precision Medicines is -11.51
What is the cash to sales ratio of Praxis Precision Medicines?
The cash to sales ratio of Praxis Precision Medicines is 579.66
What is the reporting currency for Praxis Precision Medicines?
Praxis Precision Medicines reports financial results in USD
What is the latest annual turnover for Praxis Precision Medicines?
The latest annual turnover of Praxis Precision Medicines is USD 2.45M
What is the latest annual profit for Praxis Precision Medicines?
The latest annual profit of Praxis Precision Medicines is USD -123.28M
What is the registered address of Praxis Precision Medicines?
The registered address for Praxis Precision Medicines is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Praxis Precision Medicines website address?
The website address for Praxis Precision Medicines is www.praxismedicines.com
Which industry sector does Praxis Precision Medicines operate in?
Praxis Precision Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FOXXFoxx Development Holdings Inc
$ 7.8888
(172.97%)
12.43M
AMODAlpha Modus Holdings Inc
$ 3.941
(155.91%)
102.14M
TECXTectonic Therapeutic Inc
$ 54.87
(113.34%)
3.85M
ATHEAlterity Therapeutics Limited
$ 4.55
(56.36%)
18.79M
ACONAclarion Inc
$ 14.40
(56.31%)
776.07k
CLEUChina Liberal Education Holdings Ltd
$ 0.3001
(-96.13%)
96.36M
CRGXCARGO Therapeutics Inc
$ 3.4186
(-74.08%)
14.51M
FATFAT Brands Inc
$ 3.40
(-42.08%)
159.71k
EVTVEnvirotech Vehicles Inc
$ 0.4049
(-39.30%)
2.6M
IRWDIronwood Pharmaceuticals Inc
$ 2.3493
(-36.85%)
5.65M
NVDANVIDIA Corporation
$ 119.37
(-3.50%)
163.63M
MGOLMGO Global Inc
$ 0.121
(18.98%)
134.47M
AMODAlpha Modus Holdings Inc
$ 3.941
(155.91%)
102.14M
SPGCSacks Parente Golf Inc
$ 0.7767
(31.64%)
97.97M
CLEUChina Liberal Education Holdings Ltd
$ 0.3001
(-96.13%)
96.36M

PRAX Discussion

View Posts
Monksdream Monksdream 5 months ago
PRAX near a 52/week high

👍️0
Monksdream Monksdream 1 year ago
PRAX under $2
👍️0
richme richme 1 year ago
Do you still have your 10K shares?

Hope this one goes up to new heights in $5+ in the next month or so.
👍️0
makinezmoney makinezmoney 2 years ago
$PRAX: Added 10k here now at 1.22


Technically........ bullish ...... should get to $1.80 min



GO $PRAX
👍️0
ctb ctb 2 years ago
Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study
Vandana Singh
Fri, March 3, 2023 at 8:05 AM PST

https://finance.yahoo.com/news/despite-trial-failure-praxis-still-160535252.html
👍️0
IPO$ IPO$ 2 years ago
News today.
👍️0
IPO$ IPO$ 2 years ago
Not looking good now.
👍️0
IPO$ IPO$ 2 years ago
Getting killed this am.
👍️0
IPO$ IPO$ 2 years ago
FDA phase 2 approval due in next week or so.
👍️0
IPO$ IPO$ 2 years ago
ATM offering on S-3 didn’t hurt 2022 as avg price was $3.90 per share but not sure on 2023.
👍️0
IPO$ IPO$ 2 years ago
Book value at 12/31/22 is $76M. Not bad. They say they have enough cash entering 2023.
👍️0
IPO$ IPO$ 2 years ago
$61M cash at 12/31/22 with 49M shares O/S for about $1.30 in cash per share.
👍️0
IPO$ IPO$ 2 years ago
I wonder how much cash they have now?
👍️0
ElCollector ElCollector 3 years ago
$PRAX has $5 a share cash and easily going from $2 to $3 for my collection....patiently waiting
👍️0
rtrstock rtrstock 4 years ago
Looking for a gain.
👍️0

Your Recent History

NASDAQ
PRAX
Praxis Precision Medicines
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads